EPCAM and neoplasm: EPCAM− tumour cells were also resistant to the anti-microtubule paclitaxel, the DNA intercalant and topoisomerase II inhibitor doxorubicin and ionizing radiation, although these treatments were less efficient in inducing cell death in EPCAM+ tumour cells (Fig. 1d).